Evolus Other Liab from 2010 to 2024

EOLS Stock  USD 13.04  0.41  3.25%   
Evolus Other Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Liabilities is likely to outpace its year average in 2024. From the period from 2010 to 2024, Evolus Other Liabilities quarterly data regression had r-value of  0.62 and coefficient of variation of  54.71. View All Fundamentals
 
Other Liabilities  
First Reported
2015-12-31
Previous Quarter
39 M
Current Value
39.9 M
Quarterly Volatility
25 M
 
Yuan Drop
 
Covid
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 M, Interest Expense of 14.5 M or Selling General Administrative of 81.7 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
  
Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Other Liab Growth Pattern

Below is the plot of the Other Liab of Evolus Inc over the last few years. It is Evolus' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Evolus Other Liab Regression Statistics

Arithmetic Mean36,005,301
Geometric Mean31,600,474
Coefficient Of Variation54.71
Mean Deviation16,604,988
Median21,289,000
Standard Deviation19,698,084
Sample Variance388T
Range67.2M
R-Value0.62
Mean Square Error258.3T
R-Squared0.38
Significance0.01
Slope2,721,653
Total Sum of Squares5432.2T

Evolus Other Liab History

202446.9 M
202345.9 M
202239.9 M
202144.5 M
202058.1 M
201959.1 M
201882.2 M

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Other Liab, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities45.9 M46.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.